DiabetesMine: the all things diabetes blog » Other Injectable Meds

Small But Mighty: Creating Targeted Tattoos for Injection Sites

AllisonN — Wed, 01 May 2013 11:00:59 +0000

We talked recently about how diabetes is part of a much larger chronic illness community, and that’s a strength we don’t often tap into. Sometimes innovations that can help us PWDs (people with diabetes) come from folks dealing with other…

The post Small But Mighty: Creating Targeted Tattoos for Injection Sites appeared first on DiabetesMine: the all things diabetes blog.

Sunday Funnies: Diabetes Med Wars

AmyT — Sun, 10 Feb 2013 12:00:55 +0000

In with the new, out with the old… Byetta vs. Victoza… Sometimes changing up diabetes meds can kind of feel like dealing with temperamental pets. Thanks to the talented Mike Durbin, who blogs at My…

The post Sunday Funnies: Diabetes Med Wars appeared first on DiabetesMine: the all things diabetes blog.

NewsFlash: FDA Clears First-Ever Drug for Diabetic Eye Condition

MikeH — Thu, 16 Aug 2012 20:00:51 +0000

Three extra lines on an eye chart. That may not seem like much at first glance (!), but those lines represent a significant step forward in the treatment of a form of diabetic retinopathy known as diabetic macular edema (DME).…

The post NewsFlash: FDA Clears First-Ever Drug for Diabetic Eye Condition appeared first on DiabetesMine: the all things diabetes blog.

SGLT-2 Drugs = A New Class of Medication, Since Diabetes Is Like a River

MikeH — Mon, 02 Jul 2012 11:00:58 +0000

Sometimes, diabetes science confuses me. Let’s take the news of an emerging class of diabetes drugs (type 2-focused) that apparently do something we’ve always thought was bad… but it’s actually not. Sodium-glucose transporter (SGLT-2) inhibitors increase insulin production and effectiveness…

The post SGLT-2 Drugs = A New Class of Medication, Since Diabetes Is Like a River appeared first on DiabetesMine: the all things diabetes blog.

Ask D’Mine: Weighty Matters, Chapter 2

WilD — Sat, 16 Jun 2012 11:00:41 +0000

Happy Saturday! You may experience a little deja vu on this one, as it’s a topic we addressed back in December 2011... about dealing with weight struggles. Got the dieting blues on these Weighty Matters? We hear you. Please take…

The post Ask D’Mine: Weighty Matters, Chapter 2 appeared first on DiabetesMine: the all things diabetes blog.

Ask D’Mine: Quitting Victoza, Pregnancy Insulin(s)?

WilD — Sat, 14 Apr 2012 13:00:32 +0000

There’s no end in sight when you have diabetes — but is there ever a time when it’s right to quit your meds? In this edition of our weekly diabetes advice column, Ask D’Mine, a couple of our readers are…

The post Ask D’Mine: Quitting Victoza, Pregnancy Insulin(s)? appeared first on DiabetesMine: the all things diabetes blog.

Bydureon: Changing the Paradigm for Type 2 Diabetes?

AllisonN — Wed, 15 Feb 2012 14:00:32 +0000

The biggest thing in diabetes headlines of late is Bydureon, the first and only once-a-week drug to help type 2 diabetics keep their sugars in check, which is newly approved by the FDA. Amylin’s stock price is up, and the…

The post Bydureon: Changing the Paradigm for Type 2 Diabetes? appeared first on DiabetesMine: the all things diabetes blog.

Our Interview with Paula Deen: Sticky Sweet

AmyT — Thu, 19 Jan 2012 01:24:14 +0000

Paula Deen is facing the music, on the eve of her birthday nonetheless (tomorrow). She and her publicist must have had a phone-a-thon today as she made herself available to the media, inevitably to answer to accusations of hypocrisy, profiteering,…

The post Our Interview with Paula Deen: Sticky Sweet appeared first on DiabetesMine: the all things diabetes blog.

Paula Deen’s Diabetes – Mistakes and Opportunities

AmyT — Wed, 18 Jan 2012 01:59:01 +0000

In case you haven’t heard, famous butter-and-cream Southern supreme chef Paula Deen has announced that she is a type 2 diabetic… and that she has partnered with Novo Nordisk in a campaign promoting their drug, Victoza. The way the Internet…

The post Paula Deen’s Diabetes – Mistakes and Opportunities appeared first on DiabetesMine: the all things diabetes blog.

DiaPep277: Re-Educating the Immune System

AmyT — Tue, 17 Jan 2012 14:00:33 +0000

In the area of beta cell preservation, there’s a (sort of) new name in the spotlight: Andromeda Biotech, Ltd. with its DiaPep277 treatment. Based in Israel, this company announced last month that phase III clinical trials showed significant preservation of C-peptide…

The post DiaPep277: Re-Educating the Immune System appeared first on DiabetesMine: the all things diabetes blog.